LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia and Switzerland. It offers MicroStreak, an automated culture-plate streaking and inoculation system; APAS, a platform technology for the automation of culture-plate screening and interpretation; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. The company was founded in 2004 and is headquartered in Adelaide, Australia.